TopGum secures investment from AP Partners Fund

Published: 9-Nov-2020

Manufacturing high-quality gummies with extended shelf life and attractive flavor is a significant challenge, the company says

TopGum Industries has secured an investment from AP Partners Fund, Tel Aviv. This injection is aimed to accelerate growth and expand production capacity, R&D and marketing activities to North America and Europe in 2021.

TopGum entered the Israeli confectionery market in 2004, and in 2019 launched its functional gummy supplements portfolio. This was following R&D efforts and capital investment in a GMP- and UL-certified facility.

“The new investment allows us to increase capacity significantly and expand our activity to US and the European markets,” said Amichai Bar-Nir, CEO of TopGum. “As part of the Israeli FoodTech ecosystem, TopGum is working diligently to innovate this popular delivery form, supporting our customers assiduously to stand up in the crowd with differentiated, high quality products.”

According to the 2019 NBJ supplement business report, 2018 gummy supplement sales hit US$5.5B and made up 12.5% of the dietary supplements market.

AP Partners Fund, a private equity fund, focuses on product-oriented enterprises with high growth prospective. Hagai Stadler, founding partner of AP Partners and the former CEO of Algatech, will act as Chairman of the Board for TopGum.

“As a major partner at TopGum, we will take a part in its journey to become one of the leading gummy-based supplement producers,” said Stadler. ”We were impressed by the company’s vision to provide clean-label, innovative gummy supplements with superior flavor, which will advance gummy formulations to the next level. AP Partners will work closely with TopGum management to unlock the vast potential of its innovative product line and stimulate growth.”

You may also like